Saba Capital Management, L.P. bought HQL
May 8, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 10,986 shares of Abrdn Life Sciences Investors at $13.70 per share, a transaction worth $150.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,986
Price
$13.70
Total value
$150.5K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 8, 2024
Filing dateMay 10, 2024
Shares owned after3,140,590
OwnershipIndirect
10b5-1 planNo
AmendedNo